Evidence map›Paper›PMID 20945497›Full record

ArticleThe Prostate2011

Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells.

Shengqiang Yu, Caixia Zhang, Chiu-Chun Lin, Yuanjie Niu, Kuo-Pao Lai, Hong-chiang Chang, Shauh-Der Yeh, Chawnshang Chang, Shuyuan Yeh

Abstract read
In one paragraph

Article in The Prostate, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. A novel co-culture model of human prostate epithelial and stromal cells for androgenic and antiandrogenic screening.Toxicology in vitro : an international journal published in association with BIBRA · 2023
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Role of prostate stem cells and treatment strategies in benign prostate hyperplasia.American journal of clinical and experimental urology · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Shengqiang YuGeorge H. Whipple Lab for Cancer Research, Department of Pathology, University of Rochester Medical Center, Rochester, New York 14642, USA.
Caixia Zhang
Chiu-Chun Lin
Yuanjie Niu
Kuo-Pao Lai
Hong-chiang Chang
Shauh-Der Yeh
Chawnshang Chang
Shuyuan Yeh
University of Rochester Medical Center · USChina Medical University · TW

Funding

New Mice Models for Studies of Androgen Receptor in Prostate CancerR01CA127300 · NCI · UNIVERSITY OF ROCHESTER · PI CHANG, CHAWNSHANG, YEH, SHUYUAN · 2008 to 2012
$1.6M
ERalpha in prostate homeostasis and cancerR01CA137474 · NCI · UNIVERSITY OF ROCHESTER · PI YEH, SHUYUAN · 2009 to 2014
$1.5M
NCI NIH HHS CA127300NCI NIH HHS CA137474NCI NIH HHS R01 CA127300NCI NIH HHS R01 CA137474
6 · The paper itself

Abstract

backgroundAndrogens and the androgen receptor (AR) play critical roles in the prostate development via mesenchymal-epithelial interactions. Smooth muscle cells (SMC), differentiated from mesenchyme, are one of the basic components of the prostate stroma. However, the roles of smooth muscle AR in prostate development are still obscure.

methodsWe established the smooth muscle selective AR knockout (SM-ARKO) mouse model using the Cre-loxP system, and confirmed the ARKO efficiency at RNA, DNA and protein levels. Then, we observed the prostate morphology changes, and determined the epithelial proliferation, apoptosis, and differentiation. We also knocked down the AR in a prostate smooth muscle cell line (PS-1) to confirm the in vivo findings and to probe the mechanism.

resultsThe AR was selectively and efficiently knocked out in the anterior prostates of SM-ARKO mouse. The SM-ARKO prostates have defects with loss of infolding structures, and decrease of epithelial proliferation, but with little change of apoptosis and differentiation. The mechanism studies showed that IGF-1 expression level decreased in the SM-ARKO prostates and AR-knockdown PS-1 cells. The decreased IGF-1 expression might contribute to the defective development of SM-ARKO prostates.

conclusionsThe AR in SMCs plays important roles in the prostate development via the regulation of IGF-1 signal.

Indexed as

AnimalsApoptosisEpithelial CellsEpitheliumImmunohistochemistryIn Situ Nick-End LabelingInsulin-Like Growth Factor IMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMuscle, SmoothProstateReceptors, AndrogenReverse Transcriptase Polymerase Chain ReactionInsulin-Like Growth Factor IReceptors, AndrogenRNA

Identifiers

PMID20945497
PMCPMC3037429
OpenAlexW2131915710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.